Loader

Pathways

PathWhiz ID Pathway Meta Data

PW132456

Pw132456 View Pathway
metabolic

Artemotil Drug Metabolism

Homo sapiens
Artemotil is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Artemotil passes through the liver and is then excreted from the body mainly through the kidney.

PW146684

Pw146684 View Pathway
drug action

Artemotil Drug Metabolism Action Pathway

Homo sapiens

PW127426

Pw127426 View Pathway
drug action

Artenimol Action Pathway

Homo sapiens
Artenimol is an artemisinin derivative and antimalarial agent used in the treatment of uncomplicated Plasmodium falciparum infections. It is used in combination with Piperaquine. Artemisinins, including Artenimol which is a major active metabolite of many artemisinins, are believed to bind to haem within the P. falciparum parasite. The source of this haem varies with the life stage of the parasite. When the parasite is in the early ring stage artemisinins are believed to bind haem produced by the parasite's haem biosynthesis pathway. In later stages artemisinins likely bind to haem released by haemoglobin digestion. Once bound to haem, artemisinins are thought to undergo activation involving ferrous iron via reductive scission which splits the endoperoxide bridge to produce a reactive oxygen. This reactive oxygen is thought to undergo a subsequent intramolecular hydrogen abstraction to produce a reactive carbon radical. The carbon radical is believed to be the source of the drugs potent activity against P. falciparum by alkylating a wide array of protein targets. The nature and magnitude of the effect on specific protein function as a result of this alkylation is unknown. One target which has been the focus of research is the sarco/endoplasmic reticulum Ca2+ ATPase pump of P. falciparum. Artemisinins have been found to irreversably bind to and inhibit this protein at a binding site similar to that of Thapsigargin.

PW146415

Pw146415 View Pathway
drug action

Artenimol Drug Metabolism Action Pathway

Homo sapiens

PW127429

Pw127429 View Pathway
drug action

Artesunate Action Pathway

Homo sapiens
Artesunate is artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria. Artesunate is an artemisinin derivative that is metabolized to DHA, which generates free radicals to inhibit normal function of Plasmodium parasites. Artesunate is metabolized in the liver to the active DHA. DHA enters the Plasmodium parasite. Once in the parasite iDHA reacts with heme, which generats free radicals which inhibit protein and nucleic acid synthesis of the Plasmodium parasites. Reactions with these free radicals can also lead to alkylation of parasitic proteins such as a calcium adenosine triphosphatase and EXP1, a glutathione S-transferase.

PW146063

Pw146063 View Pathway
drug action

Artesunate Drug Metabolism Action Pathway

Homo sapiens

PW145920

Pw145920 View Pathway
drug action

Articaine Drug Metabolism Action Pathway

Homo sapiens

PW145693

Pw145693 View Pathway
drug action

Arzoxifene Drug Metabolism Action Pathway

Homo sapiens

PW132547

Pw132547 View Pathway
metabolic

Asciminib Drug Metabolism

Homo sapiens
Asciminib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Asciminib passes through the liver and is then excreted from the body mainly through the kidney.

PW146544

Pw146544 View Pathway
drug action

Asciminib Drug Metabolism Action Pathway

Homo sapiens